
Everett White
Examiner (ID: 8761, Phone: (571)272-0660 , Office: P/1672 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1803, 1621, 1672, 1211, 1623, 1815, 1673 |
| Total Applications | 1695 |
| Issued Applications | 1040 |
| Pending Applications | 119 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18994647
[patent_doc_number] => 11911464
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Anti-parasitic immunological compositions
[patent_app_type] => utility
[patent_app_number] => 17/275892
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 25
[patent_no_of_words] => 10229
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275892
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275892 | Anti-parasitic immunological compositions | Sep 12, 2019 | Issued |
Array
(
[id] => 18117557
[patent_doc_number] => 11548938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => DbpA antibodies and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/546113
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 44125
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16546113
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/546113 | DbpA antibodies and uses thereof | Aug 19, 2019 | Issued |
Array
(
[id] => 15206387
[patent_doc_number] => 20190365880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => STREPTOCOCCUS PNEUMONIAE VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/542497
[patent_app_country] => US
[patent_app_date] => 2019-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16542497
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/542497 | None | Aug 15, 2019 | Issued |
Array
(
[id] => 18518514
[patent_doc_number] => 11708394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Modified meningococcal FHBP polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/265610
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 21
[patent_no_of_words] => 20601
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265610 | Modified meningococcal FHBP polypeptides | Aug 8, 2019 | Issued |
Array
(
[id] => 17127657
[patent_doc_number] => 20210302426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => METHOD FOR IMMUNOLOGICALLY DETECTING MYCOPLASMA PNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 17/264749
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264749
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264749 | METHOD FOR IMMUNOLOGICALLY DETECTING MYCOPLASMA PNEUMONIAE | Aug 4, 2019 | Abandoned |
Array
(
[id] => 17178371
[patent_doc_number] => 11155606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Antibody directed against
[patent_app_type] => utility
[patent_app_number] => 16/521223
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17588
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16521223
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/521223 | Antibody directed against | Jul 23, 2019 | Issued |
Array
(
[id] => 18091336
[patent_doc_number] => 20220409677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => NOVEL PROBIOTIC COMPOSITION FOR REGULATION OF INTESTINAL IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 17/622177
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622177 | NOVEL PROBIOTIC COMPOSITION FOR REGULATION OF INTESTINAL IMMUNITY | Jul 22, 2019 | Abandoned |
Array
(
[id] => 15035709
[patent_doc_number] => 20190328859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => CLOSTRIDIUM DIFFICILE ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 16/511503
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511503
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/511503 | CLOSTRIDIUM DIFFICILE ANTIGENS | Jul 14, 2019 | Abandoned |
Array
(
[id] => 15321057
[patent_doc_number] => 20200000858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/504980
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16504980
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/504980 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Jul 7, 2019 | Abandoned |
Array
(
[id] => 15852991
[patent_doc_number] => 10641769
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-05-05
[patent_title] => Rapid analysis for cyanobacterial toxins
[patent_app_type] => utility
[patent_app_number] => 16/433424
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 11975
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433424 | Rapid analysis for cyanobacterial toxins | Jun 5, 2019 | Issued |
Array
(
[id] => 16913997
[patent_doc_number] => 20210187089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host
[patent_app_type] => utility
[patent_app_number] => 17/057095
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057095 | Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host | May 22, 2019 | Issued |
Array
(
[id] => 18202400
[patent_doc_number] => 11584782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/404374
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 44
[patent_no_of_words] => 14899
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/404374 | None | May 5, 2019 | Issued |
Array
(
[id] => 16883805
[patent_doc_number] => 20210170000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => Larval preparation of Heligmosomoides polygyrus bakeri as well as methods of making it and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/044932
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044932 | Larval preparation of Heligmosomoides polygyrus bakeri as well as methods of making it and uses thereof | Apr 4, 2019 | Pending |
Array
(
[id] => 14564079
[patent_doc_number] => 20190209646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => BACTERIAL INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/363908
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363908
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363908 | Bacterial inhibitors | Mar 24, 2019 | Issued |
Array
(
[id] => 16598409
[patent_doc_number] => 20210024940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/638943
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638943
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638943 | RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER | Mar 13, 2019 | Pending |
Array
(
[id] => 16655326
[patent_doc_number] => 20210051962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => USES OF CYANOBACTERIUM EXTRACELLULAR POLYMER, COMPOSITIONS, COATED SURFACES OR ARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/979045
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979045
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979045 | USES OF CYANOBACTERIUM EXTRACELLULAR POLYMER, COMPOSITIONS, COATED SURFACES OR ARTICLES | Mar 7, 2019 | Abandoned |
Array
(
[id] => 16539428
[patent_doc_number] => 20200405841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Immunogenic Composition
[patent_app_type] => utility
[patent_app_number] => 16/978870
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978870
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/978870 | Immunogenic Composition | Mar 5, 2019 | Abandoned |
Array
(
[id] => 18389864
[patent_doc_number] => 20230158082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => NANOVESICLES DERIVED FROM COPROCOCCUS SP. BACTERIA, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/977692
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977692 | NANOVESICLES DERIVED FROM COPROCOCCUS SP. BACTERIA, AND USE THEREOF | Mar 4, 2019 | Abandoned |
Array
(
[id] => 17350005
[patent_doc_number] => 11224623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Agent for inducing interferon production containing lactic acid bacteria
[patent_app_type] => utility
[patent_app_number] => 16/290581
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 51
[patent_no_of_words] => 13822
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16290581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/290581 | Agent for inducing interferon production containing lactic acid bacteria | Feb 28, 2019 | Issued |
Array
(
[id] => 16539393
[patent_doc_number] => 20200405806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => COMBINATION OF A TETANUS TOXOID, ANTI-OX40 ANTIBODY AND/OR ANTI-PD-1 ANTIBODY TO TREAT TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/968507
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968507 | COMBINATION OF A TETANUS TOXOID, ANTI-OX40 ANTIBODY AND/OR ANTI-PD-1 ANTIBODY TO TREAT TUMORS | Feb 6, 2019 | Abandoned |